MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry
Launched by CORVITA SCIENCE FOUNDATION · Jun 11, 2024
Trial Information
Current as of November 07, 2025
Recruiting
Keywords
ClinConnect Summary
The MANAGE-VT Registry is a research study focused on understanding and improving care for patients with a condition called ventricular tachycardia, which is a type of fast heartbeat that can cause serious health issues. This registry aims to collect important information about how patients with this condition are treated, so doctors can learn more and provide better care in the future. The study is currently looking for participants who are 18 years old or older, regardless of gender.
If you decide to take part in this study, you will be contributing to valuable data that can help doctors understand how to manage ventricular tachycardia more effectively. Participants can expect to provide some health information, but there are no specific treatments being tested in this study. This is an opportunity to help improve care for yourself and others with similar heart conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must be at least 18 years old
- • Must not be
- Exclusion Criteria:
- • -
About Corvita Science Foundation
Corvita Science Foundation is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on developing cutting-edge therapies, the foundation collaborates with leading researchers and institutions to facilitate rigorous clinical trials across various therapeutic areas. Corvita Science Foundation prioritizes ethical standards, patient safety, and scientific integrity, ensuring that all trials are conducted with the highest quality and transparency. By fostering partnerships and leveraging scientific expertise, the foundation aims to contribute significantly to the advancement of healthcare solutions and the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported